These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38490328)
1. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma. Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328 [TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis. Zhao Y; Cui Q; Shen J; Shen W; Weng Y Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma. Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623 [TBL] [Abstract][Full Text] [Related]
4. IGF2BP3 suppresses ferroptosis in lung adenocarcinoma by m6A-dependent regulation of TFAP2A to transcriptionally activate SLC7A11/GPX4. Li P; Chu D; Ding G; Qin D; Bu Y; Tian B Mol Cell Biochem; 2024 Jul; ():. PubMed ID: 39026029 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization and clinical significance of super-enhancers in lung adenocarcinoma. Jiang X; Qin N; Hua T; Wei X; Li Y; Chen C; Gong L; Liu S; Wang C; Yin R; Jiang Y; Dai J; Xu L; Shen H; Ma H Mol Carcinog; 2022 Aug; 61(8):776-786. PubMed ID: 35596703 [TBL] [Abstract][Full Text] [Related]
7. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis in Lung Adenocarcinoma Cells]. Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883 [TBL] [Abstract][Full Text] [Related]
8. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma. Li F; Ge D; Sun SL BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754 [TBL] [Abstract][Full Text] [Related]
9. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks. Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209 [TBL] [Abstract][Full Text] [Related]
10. Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma. Liu Y; Pang Z; Wang Y; Liu J; Wang G; Du J Chem Biol Interact; 2024 Jan; 387():110794. PubMed ID: 37951334 [TBL] [Abstract][Full Text] [Related]
11. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma. Wu X; Wang S; Chen K Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821 [TBL] [Abstract][Full Text] [Related]
12. The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11. Guo Y; Wang X; Du Y; Zhao Y; Gao L; Hao Y; Lv D; Feng X; Zhai Y; Zou B; Han J; Xu E; Yang Y; Yang B; Xi Y; Zhang L Cancer Gene Ther; 2024 Oct; 31(10):1498-1510. PubMed ID: 39127833 [TBL] [Abstract][Full Text] [Related]
13. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma. Wang Z; Zhang X; Tian X; Yang Y; Ma L; Wang J; Yu Y Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846793 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis. Meng X; Peng F; Yu S; Chi X; Wang W; Shao S J Cancer Res Clin Oncol; 2024 May; 150(5):228. PubMed ID: 38700533 [TBL] [Abstract][Full Text] [Related]
15. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma. Huang Z; Chen X; Wang Y; Yuan J; Li J; Hang W; Meng H Front Immunol; 2024; 15():1372215. PubMed ID: 38655266 [TBL] [Abstract][Full Text] [Related]
16. MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1. Zhao G; Liang J; Zhang Y; Shan G; Bian Y; Gu J; Zhan C; Ge D Commun Biol; 2024 Jun; 7(1):680. PubMed ID: 38831092 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma. Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma. Li Z; Lu W; Yin F; Zeng P; Li H; Huang A J Transl Med; 2024 Apr; 22(1):340. PubMed ID: 38594779 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma. Bian Y; Shan G; Liang J; Hu Z; Sui Q; Shi H; Wang Q; Bi G; Zhan C Commun Biol; 2024 Jun; 7(1):751. PubMed ID: 38902322 [TBL] [Abstract][Full Text] [Related]
20. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma. Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]